Hidradenitis suppurativa
☆ I dtorthaí 2022 Stiftung Warentest ón nGearmáin, ní raibh sástacht na dtomhaltóirí le ModelDerm ach beagán níos ísle ná mar a bhí le comhairliúchán teileamhíochaine íoctha.
Hidradenitis suppurativa (céim I) san armpit. Is cás an-éadrom é seo de Hidradenitis suppurativa.
References
Is riocht craicinn ainsealach é Hidradenitis suppurativa , a choinníonn ag teacht ar ais, agus a chuireann isteach go mór ar do shaol. Athlasadh sna follicles gruaige is cúis leis, agus is minic go mbíonn ionfhabhtuithe baictéaracha ann. De ghnáth déanann na dochtúirí é a dhiagnóisiú trí bhreathnú ar na cineálacha cneácha atá agat (cosúil le nodules, abscesses, nó tracts sinus) , cá bhfuil siad (i bhfaillí craiceann de ghnáth) , agus cé chomh minic a thagann siad ar ais agus cé chomh fada agus a chloíonn siad timpeall.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Úsáidtear cóireálacha neamhbhitheolaíocha agus neamh-nós imeachta go coitianta leo féin le haghaidh galair éadroma agus is féidir iad a chomhcheangal le teiripe bhitheolaíoch agus máinliacht le haghaidh galar measartha go tromchúiseach. Soláthraíonn staidéir a rinneadh le déanaí fianaise bhreise maidir le héifeachtacht maidir le húsáid corticosteroidí a instealladh go díreach isteach sna loit le haghaidh bladhmanna HS agus loit logánta. Ina theannta sin, tá fianaise ann a thugann le tuiscint go bhféadfadh úsáid a bhaint as tetracyclines amháin a bheith chomh héifeachtach céanna le clindamycin a chomhcheangal le rifampicin.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Úsáidtear go leor cóireálacha le haghaidh hidradenitis suppurativa, lena n-áirítear antaibheathaigh, retinoids, antiandrogens, drugaí imdhíonachta-shochtadh, míochainí frith-athlastacha, agus radaiteiripe le haghaidh loit luatha. Is iad na cóireálacha is fearr a mholtar ná adalimumab agus teiripe léasair. Is í máinliacht, máistreacht shimplí nó máistreacht áitiúil iomlán le grafadh craicinn, an rogha is fearr le haghaidh cásanna tromchúiseacha ardchéime nach bhfreagraíonn go maith do chóireálacha eile.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Is gnách nach mbíonn an chúis bheacht soiléir, ach creidtear go bhfuil meascán d’fhachtóirí géiniteacha agus comhshaoil i gceist leis. Tá tionchar ag thart ar thrian de na daoine a bhfuil an galar orthu. I measc fachtóirí riosca eile tá murtall agus caitheamh tobac. Ní ionfhabhtú, drochshláinteachas is cúis leis an riocht.
Níl aon leigheas ar eolas. Ní bhíonn buntáiste suntasach mar thoradh ar na loit a oscailt chun ligean dóibh draenáil. Cé go n-úsáidtear antaibheathaigh go coitianta, is beag an fhianaise maidir lena n-úsáid. Féadfar cógas imdhíon-bhrú a thriail freisin. I measc na ndaoine sin a bhfuil galar níos tromchúisí orthu, d’fhéadfadh go mbeadh teiripe léasair nó máinliacht chun an craiceann lena mbaineann a bhaint inmharthana. Is annamh a d’fhéadfadh lot craicinn a bheith ina ailse craicinn.
Má áirítear cásanna éadrom hidradenitis suppurativa , ansin tá an meastachán ar a mhinicíocht ó 1-4% den daonra. Tá trí huaire níos dóchúla go ndéanfaí diagnóisíodh le mná ná fir. Is i ndaoine fásta óga a tharlaíonn sé go hiondúil.